Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Prospective, randomised, single-blind study for validation of the effect of endoscopic stent implantation and drainage on patients with chronic pancreatitis and pancreas duct stenosis
ISRCTN ISRCTN13044540
ClinicalTrials.gov identifier
Public title Prospective, randomised, single-blind study for validation of the effect of endoscopic stent implantation and drainage on patients with chronic pancreatitis and pancreas duct stenosis
Scientific title
Acronym PAGASTE
Serial number at source N/A
Study hypothesis The background is the already aged obstruction hypothesis. It is assumed that a relevant stricture of the pancreatic duct leads to retention and stasis of the pancreatic juice thereby mitigating pain and inflammation. If the stent achieves a drainage the frequency of episodes of pain and inflammation should be significantly reduced.

Please note that as of 08/09/09 the contact address and ethics approval have been updated. Please also note that the end date of this trial has been extended from 01/04/07 to 31/12/2010.
Lay summary
Ethics approval Added 08/09/09: Received from Leipzig Medical Faculty ethics committee, University of Leipzig on the 14th of April 2004
Study design Randomised controlled trial
Countries of recruitment Germany
Disease/condition/study domain Chronic pancreatitis with pancreatic duct stenosis
Participants - inclusion criteria 1. Chronic pancreatitis with evidence of magnetic resonance cholangiopancreatography (MRCP) or endoscopic retrograde cholangiopancreatography (ERCP)
pancreatic duct stricture (>50%) in pancreatic head
2. Chronic recurrent pain
3. Age >18, <75, WIC
Participants - exclusion criteria 1. Radiation of upper abdominal or lower chest area
2. Uncured cancer or systemic chemotherapy within last 5 years
3. Failure of compliance
4. Foreseeable
pregnancy
5. Participation in other therapeutic trials within last 30 days
6. Patients continuous free of symptoms
Anticipated start date 01/05/2004
Anticipated end date 31/12/2010
Status of trial Completed
Patient information material
Target number of participants 40
Interventions Endoscopic stenting of the pancreatic duct, stent exchange after 3 months versus conservative treatment with analgesics
Primary outcome measure(s) Total pain score during first 3 month after ERCP, specialised Pancreas Pain Questionaire checked for reliability and validity
Secondary outcome measure(s) 1. Use af analgesics
2. Frequency of pain episodes within one year
3. Treatment failure
4. Signs of endocrine/exocrine failure
5. Change of diameter of pancreatic duct during treatment
Sources of funding University of Leipzig (Germany)
Trial website
Publications
Contact name Prof  Volker  Keim
  Address Liebigstrasse 20
Medical Clinic for Gastroenterology and Rheumatology (Medizinische Klinik für Gastroenterologie und Rheumatologie)
University Hospital Leipzig (Universitätsklinikum Leipzig AöR)
  City/town Leipzig
  Zip/Postcode 04103
  Country Germany
  Tel +49 (0)3419712233
  Fax +49 (0)3419712209
  Email keimv@medizin.uni-leipzig.de
Sponsor University of Leipzig (Germany)
  Address Liebigstrasse 20
Department of Surgery II
  City/town Leipzig
  Zip/Postcode 04103
  Country Germany
Date applied 20/09/2005
Last edited 08/09/2009
Date ISRCTN assigned 21/10/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central